Relation of TNFA, TNFB and TNFRII Gene Polymorphisms to Outcomes after Unrelated Haematopoietic Cell Transplantation Within Chinese Population
H. Xiao,X. Lai,G. Wu,Y. Luo,J. Shi,Y. Tan,X. Han,X. Zhu,J. Zhu,W. Xie,J. He,Z. Cai,M. Lin,X. Ye,H. Huang
DOI: https://doi.org/10.1016/j.bbmt.2009.12.363
2010-01-01
Biology of Blood and Marrow Transplantation
Abstract:The genes code TNFα (TNFA), TNFβ (TNFB) and TNF receptor II (TNFRII) contain multiple single nucleotide polymorphisms (SNPs). The present study was designed to test association of these genes polymorphisms with outcomes after unrelated HSCT within Chinese population. A total of 138 pairs of donors and recipients, who had undergone HSCT from 2001 to 2009 at our center, were tested for TNFA-1031(T>C), -863(C>A), -857(C>T), -238(G>A), TNFB+252(A>G) and TNFRII codon 196 (T>G) genotypes. (1) Recipients and/or donors with TNFA-857 C/C genotype or TNFB+252 G allele-positive had a higher incidence of aGVHD (P<0.05). TNFRII 196 T/T genotype in donors side or recipients side showed a stronger trend toward development of aGVHD (in donor side: P=0.028; in recipient side: P=0.086). When these effects were analyzed only in 96 pairs of HLA matched cases, donor and/or recipient TNFA-857 and TNFB+252 genotype also affected aGVHD incidence. The influence of TNFRII genotype was not significant except the recipient type showed a trend (P=0.074).The genotypes of TNFA -1031, -863 and -238 were not found to be associated with the risk of aGVHD. (2) TNFA-857, TNFB+252 and TNFRII 196 polymorphic features, together with other factors were subjected to multivariate analysis for aGVHD. Myeloablative conditioning(RR=3.771, P=0.004), donor with TNFA-857C/C genotype (RR=2.29, P=0.006) and recipient with TNFB+252 G allele-positive (RR=1.789, P=0.036) were found to significantly contribute to the development of aGVHD. Donor-recipient gender was found to be a less significant factor (P=0.079). As to grade II-IV aGVHD, myeloablative conditioning (RR=3.929, P=0.022), HLA mismatching (RR=1.691, P=0.048) and donor with TNFA-857 C/C genotype (RR=3.748, P=0.002) were found to have significant influence. Recipient with TNFB+252 G allele-positive was a less significant factor (RR=1.823, P=0.063). (3) Relapse was observed more frequently among patients who had not previously developed aGVHD (P=0.03). Except TNFRII 196 T/T genotype in recipients side was related to lower relapse rate(P=0.05), no significant association was found between cytokine genes polymorphisms with cGVHD, relapse and overall survival. These results, which is the first report of TNFA, TNFB and TNFRII polymorphic features of Chinese population with the outcomes of HSCT, suggest an interaction of TNFA-857, TNFB+252 genotypes on risk of aGVHD.